Opportunity Information: Apply for PAR 22 226
The NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award is an NIH training-focused grant opportunity (R25; independent clinical trial not allowed) run by the National Institute on Aging (NIA). Its core aim is to build and strengthen entrepreneurial training programs that help scientists translate aging-related research into real-world products, services, and solutions. Rather than funding a traditional research project, this program is meant to support structured training and immersion experiences that expand career-ready skills, especially for people who may pursue paths beyond the standard academic research track.
The program is geared toward developing entrepreneurship-oriented curricula and experiences for graduate students and postdoctoral researchers, along with early-career scientists holding masters, Ph.D., or Dr.P.H. degrees. The training focus must align with NIA's mission areas, which include aging biology, geroscience, age-related clinical and social/behavioral research, and Alzheimer’s disease and related dementias (often referenced as AD). The overarching goal is to broaden trainees' skillsets so they can navigate a wider set of careers, including roles in industry, startups, venture creation, technology transfer, commercialization, product development, regulatory science, and other innovation-oriented settings connected to aging and AD.
This opportunity is identified as PAR-22-226 and falls under a discretionary grant mechanism in the health funding activity category (CFDA 93.866). The award ceiling is listed at $250,000, indicating the maximum amount that may be provided under the terms of the opportunity (exact budgets, project periods, and allowable cost structures typically depend on NIH and FOA-specific guidance, but the ceiling provides a practical cap for planning). The original closing date is October 17, 2024, which signals the last date applications were accepted under the listed schedule for that cycle.
A notable boundary of the program is embedded in the title: "Independent Clinical Trial Not Allowed." In practical terms, applicants should not propose an independent clinical trial as the core activity under this R25. The emphasis is on training program development and implementation, not running clinical trials, and applicants are expected to keep proposed activities within NIH's definition of allowable training and educational program work for this mechanism.
Eligibility is broad across U.S.-based organizations and includes many types of government entities and institutions. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (when not institutions of higher education); for-profit organizations other than small businesses; and small businesses, among others. The opportunity explicitly highlights additional eligible organizational categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions, reflecting a strong openness to varied institutional settings that can deliver effective entrepreneurship training.
At the same time, the announcement is clear about restrictions related to foreign participation. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined in the NIH Grants Policy Statement) are not allowed. In short, the applicant organization and the supported program components must be U.S.-based without foreign components.
Overall, this REDI R25 opportunity is best understood as capacity-building support for entrepreneurship education and immersion programs tied to aging and Alzheimer’s-related science. Competitive proposals will typically be those that can convincingly show a well-designed training structure, meaningful experiential learning opportunities, and a clear pathway for trainees to gain practical skills for innovation and commercialization, all while staying within the non-clinical-trial, training-centric boundaries of the R25 mechanism.Apply for PAR 22 226
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2022-08-24.
- Applicants must submit their applications by 2024-10-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required)
Previous opportunity: Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 22 226
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 22 226) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) Apply for PAR 22 227 Funding Number: PAR 22 227 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed) Apply for PAR 22 235 Funding Number: PAR 22 235 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) Apply for PAR 23 027 Funding Number: PAR 23 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32) Apply for RFA HS 22 010 Funding Number: RFA HS 22 010 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed) Apply for RFA AG 23 018 Funding Number: RFA AG 23 018 Agency: National Institutes of Health Category: Health Funding Amount: $16,200,000 |
| Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed) Apply for PAR 22 204 Funding Number: PAR 22 204 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) Apply for RFA OD 22 013 Funding Number: RFA OD 22 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Apply for PAR 22 225 Funding Number: PAR 22 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) Apply for PAR 22 250 Funding Number: PAR 22 250 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Apply for PA 22 251 Funding Number: PA 22 251 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Limited Competition: The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL) (U24 Clinical Trial Not Allowed) Apply for RFA HG 22 020 Funding Number: RFA HG 22 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) Apply for PAR 22 254 Funding Number: PAR 22 254 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| The NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space Clinical Resource (ACR) (U24 Clinical Trial Not Allowed) Apply for RFA HG 22 021 Funding Number: RFA HG 22 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) Apply for RFA MH 22 270 Funding Number: RFA MH 22 270 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (U43/U44 - Clinical Trail Not Allowed) Apply for RFA TR 22 032 Funding Number: RFA TR 22 032 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed) Apply for RFA NS 22 031 Funding Number: RFA NS 22 031 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Data Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - DCC) (U01 Clinical Trial Not Allowed) Apply for RFA NS 22 030 Funding Number: RFA NS 22 030 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) Apply for RFA MH 22 271 Funding Number: RFA MH 22 271 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 22 241 Funding Number: PAR 22 241 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed) Apply for RFA TR 22 031 Funding Number: RFA TR 22 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 22 226", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
